Results 201 to 210 of about 3,269,992 (265)
Some of the next articles are maybe not open access.
Prevention and Tocolytic Agents 2
Preterm Labor and Delivery, 2019Preterm birth is the single most important determinant of adverse infant outcomes, in terms of survival and quality of life. Preterm infants are particularly vulnerable to complications with the increasing contribution of neonatal deaths to overall child mortality.
M. Ohashi
openaire +2 more sources
Effect of tocolytic agents on fetal umbilical velocimetry
American Journal of Obstetrics and Gynecology, 1990In this prospective study, we sought to examine the changes in umbilical vascular resistance induced by tocolytic therapy. Umbilical artery velocimetry was performed in 46 patients with preterm labor before tocolysis and at 1 hour and 24 hours after tocolysis was initiated.
J W, Wright +3 more
openaire +3 more sources
Therapeutic Agents in Preterm Labor: Tocolytic Agents
Clinical Obstetrics and Gynecology, 2000A E, Hearne, D A, Nagey
openaire +3 more sources
Magnesium sulfate as a tocolytic agent
Seminars in Perinatology, 2001Although magnesium sulfate is widely used as a tocolytic agent in the hope of preventing spontaneous preterm birth, there is a paucity of data from large well-designed randomized clinical studies demonstrating the efficacy of magnesium sulfate therapy. Given the potential for untoward side effects and the inherent risks of magnesium sulfate therapy, a ...
P S, Ramsey, D J, Rouse
openaire +2 more sources
Leptin – A tocolytic agent for the future?
Medical Hypotheses, 2010Leptin - a protein hormone is synthesised in the adipose tissue in humans. Its level therefore should be directly proportional to the amount of adipose tissue in the body. When biopsies of human myometrium from obese women were exposed to leptin, it showed a cumulative inhibitory effect on spontaneous as well as induced contractions.
Rekha, Wuntakal, Tony, Hollingworth
openaire +2 more sources
Pharmacology of Tocolytic Agents
Clinics in Obstetrics and Gynaecology, 1984Various drugs have been used to inhibit preterm labour. Selective beta-receptor agonists are the drugs of choice and have been extensively studied for more than ten years. Several controlled studies have demonstrated a significant prolongation of the pregnancy after treatment with beta-receptor agonists and some have demonstrated improved fetal outcome.
openaire +2 more sources
Evidence for Magnesium Sulfate as a Tocolytic Agent
Obstetrical & Gynecological Survey, 1997The objective of our study is to quantitatively examine the available evidence regarding the efficacy and side effects of magnesium sulfate for acute tocolysis (from randomized trials) compared with placebo and beta-agonist agents. Randomized trials comparing magnesium sulfate with placebo or beta-agonists for tocolysis were identified with a MEDLINE ...
G A, Macones +4 more
openaire +2 more sources
Magnesium sulfate as a tocolytic agent
American Journal of Obstetrics and Gynecology, 1983Magnesium sulfate (MgSO4) has been successfully used to inhibit premature labor. A retrospective review was performed on the use of MgSO4 as a tocolytic agent at Memorial Hospital, Long Beach, California, during a 4-year period (1978-1982). Three hundred fifty-five patients with diagnoses of premature labor were treated with MgSO4 after transport from ...
openaire +2 more sources
Long-Term Use of Magnesium Sulfate as a Tocolytic Agent
Obstetrics & Gynecology, 1986Two patients in premature labor were treated continuously for six and 13 weeks with intravenous magnesium sulfate (MgSO4) for tocolysis. In each case, conventional therapy with intravenous and oral ritodrine failed to abate uterine contractions, and attempts to taper the MgSO4 were unsuccessful.
I A, Wilkins +5 more
openaire +2 more sources